Golden State Equity Partners’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Golden State Equity Partners’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$16K	Buy	2,255 +110	+5%	+$1.08K	0.01%	194
2021 Q4	$28K	Buy	+2,145	New	+$35.5K	0.01%	174

Other funds holding ORTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Golden State Equity Partners's ORTX Position: Q1 2022 in Review

Golden State Equity Partners increased its Orchard Therapeutics plc American Depositary Shares (ORTX) stake by 5.1% in Q1 2022, buying an estimated $1.08K and bringing the position to 2,255 shares worth $16K. The position accounts for 0.01% of the portfolio, ranked #194.

Golden State Equity Partners first reported a position in ORTX in Q4 2021 and has held it in 2 quarters since. The position peaked at $28K in Q4 2021. 61 funds tracked by Wall St. Rank hold ORTX as of Q1 2022.

Golden State Equity Partners held 2,255 shares of Orchard Therapeutics plc American Depositary Shares worth $16K as of Q1 2022.
Golden State Equity Partners bought 110 Orchard Therapeutics plc American Depositary Shares shares in Q1 2022, an estimated $1.08K.
Orchard Therapeutics plc American Depositary Shares made up 0.01% of Golden State Equity Partners's portfolio in Q1 2022, its #194 holding.
Golden State Equity Partners first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2021 and has held it in 2 quarters since.
Golden State Equity Partners's Orchard Therapeutics plc American Depositary Shares position peaked at $28K in Q4 2021.
61 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2022.

Based on Golden State Equity Partners's 13F filing for Q1 2022, filed 16 May 2022.